Del Giudice Matthew Paul — SEC Form 4 filings

SEC reporting owner CIK 2016630. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-27.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-27 to 2026-07-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Telomir Pharmaceuticals, Inc. (TELO)Director34
MIRA PHARMACEUTICALS, INC. (MIRA)Director33

Form 4 filings — Del Giudice Matthew Paul

FiledFormIssuerReported transactionsSource
2026-07-274Telomir Pharmaceuticals, Inc. (TELO)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-06-154MIRA PHARMACEUTICALS, INC. (MIRA)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-05-224Telomir Pharmaceuticals, Inc. (TELO)Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative)EDGAR
2024-12-104MIRA PHARMACEUTICALS, INC. (MIRA)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-08-294Telomir Pharmaceuticals, Inc. (TELO)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-03-274MIRA PHARMACEUTICALS, INC. (MIRA)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2016630 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →